Selection of potential probiotic bifidobacteria and prebiotics for elderly by using in vitro faecal batch cultures

European Food Research and Technology

Volumn 243, Issue 1, 2017, Pages 157-165

  Valdes L ^a   Salazar, N ^a   Gonzalez S ^b   Arboleya, S ^a   Rios Covian D ^a   Genoves S ^c   Ramon D ^c   de los Reyes Gavilan C G ^a   Ruas Madiedo, P ^a   Gueimonde, M ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c Biópolis SL ^*  (Spain)

Author keywords

Bifidobacterium; Elder; Fructooligosaccharides; Inulin; Microbiota; Probiotics

Indexed keywords

BATCH CELL CULTURE; ENZYME ACTIVITY; FATTY ACIDS; FUNCTIONAL FOOD; GAS CHROMATOGRAPHY; POLYMERASE CHAIN REACTION;

BIFIDOBACTERIUM; ELDER; FRUCTO-OLIGOSACCHARIDES; INULIN; MICROBIOTAS; PROBIOTICS;

FOOD MICROBIOLOGY;

EID: 84975257496     PISSN: 14382377     EISSN: 14382385     Source Type: Journal    
DOI: 10.1007/s00217-016-2732-y     Document Type: Article

References (38)

1. Sanderson WC, Scherbov S (2010) Demography. Remeasuring aging. Science 329:1287–1288
2. Arboleya S, González S, Salazar N, Ruas-Madiedo P, de los Reyes-Gavilán CG, Gueimonde M (2012) Development of probiotic products for specific human populations. Eng Life Sci 12:368–376
3. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Satokari R, Franceschi C, Brigidi P, De Vos W (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5:e10667
4. Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O’Connor M, Harnedy N, O’Connor K, Henry C, O’Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O’Toole PW (2011) Composition, variability and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108:4586–4591
5. Mäkivuokko H, Tiihonen K, Tynkkynen S, Paulin L, Rautonen N (2010) The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br J Nutr 103:227–234
6. Tiihonen K, Tynkkynen S, Ouwehand AC, Ahlroos T, Rautonen N (2008) The efect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. Br J Nutr 100:130–137
7. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027–1033
8. Salazar N, López P, Valdés L, Margolles A, Suárez A, Patterson AM, Cuervo A, de los Reyes-Gavilán CG, Ruas-Madiedo P, Gonzalez S, Gueimonde M (2013) Microbial targets for the development of functional foods accordingly with nutritional and immune parameters altered in the elderly. J Am Coll Nutr 32:399–406
9. Bartosch S, Fite A, Macfarlane GT, McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70:3575–3581
10. Tiihonen K, Ouwehand AC, Rautonen N (2010) Human intestinal microbiota and healthy ageing. Ageing Res Rev 9:107–116
11. Woodmansey EJ (2007) Intestinal bacteria and ageing. J Appl Microbiol 102:1178–1186
12. Hopkins MJ, Sharp R, Macfarlane GT (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48:198–205
13. Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70:6113–6122
14. Gueimonde M, Ouwehand A, Pitkala K, Standberg T, Finne-Soveri H, Salminen S (2010) Fecal Bifidobacterium levels in elderly nursing home patients—Are levels as expected? Biosci Microflora 29:111–113
15. Bouhnik Y, Achour L, Paineau D, Riottot M, Attar A, Bornet F (2007) Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutr J 6:42
16. Forssten SD, Salazar N, López P, Nikkilä J, Ouwehand A, Paterson A, Ruas-Madiedo P, Suarez A, Gonzalez S, Gueimonde M (2011) Influence of a probiotic milk drink, containing Lactobacillus paracasei Lpc-37, on immune function and gut microbiota in elderly subjects. Eur J Food Res Rev 1:159–172
17. Fukushima Y, Miyaguchi S, Yamano T, Kaburagi T, Lino H, Ushida K, Sato K (2007) Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 98:969–977
18. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833–839
19. Ibrahim F, Ruvio S, Granlund L, Salminen S, Viitanen M, Ouwehand AC (2010) Probiotics and immunosenescence: cheese as a carrier. FEMS Immunol Med Microbiol 59:53–59
20. Schiffrin EJ, Thomas DR, Kumar VB, Brown C, Hager C, Van’t Hof MA, Morley JE, Guigoz Y (2007) Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging 11:475–479
21. Takeda K, Okumura K (2007) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137:S791–S793
22. Arboleya S, Salazar N, Solis G, Fernandez N, Gueimonde M, de los Reyes-Gavilán CG (2013) In vitro evaluation of the impact of human background microbiota on the response to Bifidobacterium strains and fructo-oligosaccharides. Br J Nutr 110:2030–2036
23. Grzeskowiak L, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E (2012) The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 18:7–13
24. Van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M (2011) Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA 108:4562–4569
25. Arboleya S, Salazar N, Solis G, Fernandez N, Hernandez-Barranco AM, Cuesta I, Gueimonde M, de los Reyes-Gavilán CG (2013) Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates. Anaerobe 19:9–16
26. Salazar N, Ruas-Madiedo P, Kolida S, Collins M, Rastall R, Gibson G, de los Reyes-Gavilán CG (2009) Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Int J Food Microbiol 135:260–267
27. Salazar N, Binetti A, Gueimonde M, Alonso A, Garrido P, González del Rey C, González C, Ruas-Madiedo P, de los Reyes-Gavilán CG (2011) Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats. Int J Food Microbiol 144:342–351
28. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101:541–550
29. Beards E, Tuohy K, Gibson G (2010) Bacterial, SCFA and gas profiles of a range of food ingredients following in vitro fermentation by human colonic microbiota. Anaerobe 16:420–425
30. Shen Q, Tuohy KM, Gibson GR, Ward RE (2011) In vitro measurement of the impact of human milk oligosaccharides on the faecal microbiota of weaned formula-fed infants compared to a mixture of prebiotic fructooligosaccharides and galactooligosaccharides. Lett Appl Microbiol 52:337–343
31. Tzortzis G, Goulas AK, Baillon ML, Gibson G, Rastall RA (2004) In vitro evaluation of the fermentation properties of galactooligosaccharides synthesised by alpha-galactosidase from Lactobacillus reuteri. Appl Microbiol Biotechnol 64:106–111
32. Valdés L, Salazar N, Gullón P, Ríos D, González-Muñoz MJ, Parajó JC, Ruas-Madiedo P, Gueimonde M, de los Reyes-Gavilán CG (2013) Population dynamics of some relevant intestinal microbial groups in human fecal batch cultures with added fermentable xylooligosaccharides obtained from rice husks. Bioresources 8:2429–2441
33. Likotrafiti E, Tuohy KM, Gibson GR, Rastall RA (2014) An in vitro study of the effect of probiotics, prebiotics and synbiotics on the elderly faecal microbiota. Anaerobe 27:50–55
34. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–341
35. Kim S-W, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, Morita H, Hattori M (2013) Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 20:241–253
36. Senan S, Prajapati JB, Joshi CG, Sreeja V, Gohel MK, Trivedi S, Patel RM, Pandya H, Singh US, Phatal A, Patel HA (2015) Geriatric respondents and non-respondents to probiotic intervention can be differentiated by inherent gut microbiome composition. Front Microbiol 6:944
37. Saulnier DMA, Gibson GR, Kolida S (2008) In vitro effects of selected synbiotics on the human faecal microbiota composition. FEMS Microbiol Ecol 66:516–527
38. Arboleya S, Binetti A, Salazar N, Fernández N, Solís G, Hernández-Barranco A, Margolles A, de los Reyes-Gavilán CG, Gueimonde M (2012) Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol 79:763–772